Tenax Therapeutics Inc.

TENX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.94

+$0.06 (+3.19%)

At close: Sep 22, 2026, 4:00 PM ET

$1.94

$0 (0.00%)

After-hours: Sep 22, 2026, 7:51 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.19%

(1D)

Rating

Updated: Aug 19, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $51.46M

1D Range

1.88 1.95

52W Range

1.31 19.40

Valuation (TTM)

PE -1.26

PB 0.44

EV/EBITDA 1.45

Valuation (NTM)

Forward PE N/A

Forward PEG 2.36

Price Target $4.40

Cash Flow

FCF Yield -92.3%

SBC Adj. FCF Yield -87.1%

SBC Impact -5.6%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 126.4% | 84.5%

FCF 3Y | 5Y -67.1% | -40.5%

Returns

ROA -53.3%

ROE -61.5%

ROIC -60.4%

Financial Health

Net Cash

$117.98M

Current Ratio 15.07

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the Uni...

Sector Healthcare

Industry Biotechnology

Employees 15

IPO Date Apr 3, 1994

Website www.tenaxthera.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

Upside

+106.19%

Buy (3)

Hold (3)

Sell (0)

Analyst Details ➞